Stock Scorer

Bioventus Inc. (BVS)

Bioventus Inc. reported revenue of 153.2M USD for the quarter ending 27 June 2026, up 3.8% from 147.7M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 27 June 2026 153.2M +3.8%
Gross Profit Q2 '26 · ending 27 June 2026 105.7M +3.5%
Operating Income Q2 '26 · ending 27 June 2026 19.1M +4.1%
Net Income Q2 '26 · ending 27 June 2026 33.4M +348.3%
Cost of Revenue Q2 '26 · ending 27 June 2026 47.5M +4.3%
Operating Cash Flow Q2 '26 · ending 27 June 2026 19.9M -23.4%
Free Cash Flow Q2 '26 · ending 27 June 2026 18.9M -25.1%
Shares Outstanding Q2 '26 · ending 27 June 2026 70.8M +7.3%
EPS Q2 '26 · ending 27 June 2026 0.77 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 568.1M54M22.7M72.1M
20242024-12-31 573.3M-15.2M-36.1M37.8M
20232023-12-31 512.3M-81.7M-156.2M8M
20222022-12-31 512.1M-167.2M-158.7M-15M
20212021-12-31 430.9M12.1M19.4M9.5M
20202020-12-31 321.2M21.2M16.4M55.2M
20192019-12-31 340.1M31.2M6.9M38.4M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-27153.2M
Q1 '262026-03-28132.1M
Q4 '252025-12-31157.9M
Q3 '252025-09-27138.7M
Q2 '252025-06-28147.7M
Q1 '252025-03-29123.9M
Q4 '242024-12-31153.6M
Q3 '242024-09-28139M
Q2 '242024-06-29151.2M
Q1 '242024-03-30129.5M
Q4 '232023-12-31135.4M
Q3 '232023-09-30120.8M
Q3 '232023-07-01137.1M
Q2 '232023-04-01119.1M
Q4 '222022-12-31125.8M
Q4 '222022-10-01128.7M
Q3 '222022-07-02140.3M
Q2 '222022-04-02117.3M
Q4 '212021-12-31130.4M
Q4 '212021-10-02108.9M

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '262026-06-27105.7M
Q1 '262026-03-2890.8M
Q4 '252025-12-31108.8M
Q3 '252025-09-2794.2M
Q2 '252025-06-28102.1M
Q1 '252025-03-2983.1M
Q4 '242024-12-31102.7M
Q3 '242024-09-2893.6M
Q2 '242024-06-29103.6M
Q1 '242024-03-3088.4M
Q4 '232023-12-3186.3M
Q3 '232023-09-3078.8M
Q3 '232023-07-0189.1M
Q2 '232023-04-0173.9M
Q4 '222022-12-3174.2M
Q4 '222022-10-0184.5M
Q3 '222022-07-0296.7M
Q2 '222022-04-0275.7M
Q4 '212021-12-3187.8M
Q4 '212021-10-0279.1M

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-2719.1M
Q1 '262026-03-288.4M
Q4 '252025-12-3119.5M
Q3 '252025-09-2711.3M
Q2 '252025-06-2818.4M
Q1 '252025-03-294.9M
Q4 '242024-12-317.7M
Q3 '242024-09-283.6M
Q2 '242024-06-29-31.5M
Q1 '242024-03-304.9M
Q4 '232023-12-311.2M
Q3 '232023-09-302.4M
Q3 '232023-07-016.8M
Q2 '232023-04-01-92.1M
Q4 '222022-12-31-15.6M
Q4 '222022-10-01-126.8M
Q3 '222022-07-02-3.3M
Q2 '222022-04-02-21.4M
Q4 '212021-12-31-3.1M
Q4 '212021-10-02-1M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-2733.4M
Q1 '262026-03-283.1M
Q4 '252025-12-3114.8M
Q3 '252025-09-273.2M
Q2 '252025-06-287.5M
Q1 '252025-03-29-2.6M
Q4 '242024-12-31-388K
Q3 '242024-09-28-5.2M
Q2 '242024-06-29-25.7M
Q1 '242024-03-30-4.9M
Q4 '232023-12-31-6.1M
Q3 '232023-09-30-7.3M
Q3 '232023-07-01-3.7M
Q2 '232023-04-01-139.2M
Q4 '222022-12-31-31.9M
Q4 '222022-10-01-108.2M
Q3 '222022-07-02-7.3M
Q2 '222022-04-02-11.3M
Q4 '212021-12-31-364K
Q4 '212021-10-02-1.1M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-2747.5M
Q1 '262026-03-2841.3M
Q4 '252025-12-3149.1M
Q3 '252025-09-2744.4M
Q2 '252025-06-2845.6M
Q1 '252025-03-2940.8M
Q4 '242024-12-3151M
Q3 '242024-09-2845.4M
Q2 '242024-06-2947.6M
Q1 '242024-03-3041.1M
Q4 '232023-12-3149.1M
Q3 '232023-09-3041.9M
Q3 '232023-07-0147.9M
Q2 '232023-04-0145.1M
Q4 '222022-12-3151.6M
Q4 '222022-10-0144.1M
Q3 '222022-07-0243.7M
Q2 '222022-04-0241.6M
Q4 '212021-12-3142.6M
Q4 '212021-10-0229.8M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-2719.9M
Q1 '262026-03-288.9M
Q4 '252025-12-3138M
Q3 '252025-09-2730.1M
Q2 '252025-06-2825.9M
Q1 '252025-03-29-19.3M
Q4 '242024-12-3119.3M
Q3 '242024-09-2810.3M
Q2 '242024-06-2915.2M
Q1 '242024-03-30-6M
Q4 '232023-12-3110.4M
Q3 '232023-09-30-8.3M
Q3 '232023-07-0110.8M
Q2 '232023-04-012.5M
Q4 '222022-12-315.2M
Q4 '222022-10-01-701K
Q3 '222022-07-022.9M
Q2 '222022-04-02-21M
Q4 '212021-12-3113.1M
Q4 '212021-10-0210.6M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-2718.9M
Q1 '262026-03-288.4M
Q4 '252025-12-3137.4M
Q3 '252025-09-2729.6M
Q2 '252025-06-2825.3M
Q1 '252025-03-29-20.2M
Q4 '242024-12-3118.7M
Q3 '242024-09-2810.3M
Q2 '242024-06-2915.1M
Q1 '242024-03-30-6.3M
Q4 '232023-12-3110M
Q3 '232023-09-30-10.4M
Q3 '232023-07-019.4M
Q2 '232023-04-01-1.1M
Q4 '222022-10-01-2.4M
Q3 '222022-07-02909K
Q2 '222022-04-02-24M
Q4 '212021-12-314.2M
Q4 '212021-10-028.7M
Q3 '212021-07-0316.1M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-2770.8M
Q1 '262026-03-2870M
Q3 '252025-09-2768.8M
Q2 '252025-06-2868.5M
Q1 '252025-03-2966M
Q3 '242024-09-2865.3M
Q2 '242024-06-2964.1M
Q1 '242024-03-3063.4M
Q3 '232023-09-3062.8M
Q3 '232023-07-0162.6M
Q2 '232023-04-0162.1M
Q4 '222022-10-0161.7M
Q3 '222022-07-0261.5M
Q2 '222022-04-0260.5M
Q4 '212021-10-0241.8M
Q3 '212021-07-0341.8M
Q2 '212021-04-0341.8M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-270.77
Q1 '262026-03-280.41
Q4 '252025-12-310.33
Q3 '252025-09-270.12
Q2 '252025-06-28-0.01
Q1 '252025-03-29-0.52
Q4 '242024-12-31-0.56
Q3 '242024-09-28-0.65
Q2 '242024-06-29-0.69
Q1 '242024-03-30-0.35
Q4 '232023-12-31-2.51
Q3 '232023-09-30-2.94
Q3 '232023-07-01-4.58
Q2 '232023-04-01-4.63
Q4 '222022-12-31-2.58
Q4 '222022-10-01-2.06
Q3 '222022-07-02-0.33
Q2 '222022-04-02-0.32